Cargando…

Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation

Detalles Bibliográficos
Autores principales: Correnti, Colin E., Laszlo, George S., de van der Schueren, Willem J., Godwin, Colin D., Bandaranayake, Ashok, Busch, Melanie A., Gudgeon, Chelsea J., Bates, Olivia M., Olson, James M., Mehlin, Christopher, Walter, Roland B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943151/
https://www.ncbi.nlm.nih.gov/pubmed/29588544
http://dx.doi.org/10.1038/s41375-018-0014-3
_version_ 1783321578932535296
author Correnti, Colin E.
Laszlo, George S.
de van der Schueren, Willem J.
Godwin, Colin D.
Bandaranayake, Ashok
Busch, Melanie A.
Gudgeon, Chelsea J.
Bates, Olivia M.
Olson, James M.
Mehlin, Christopher
Walter, Roland B.
author_facet Correnti, Colin E.
Laszlo, George S.
de van der Schueren, Willem J.
Godwin, Colin D.
Bandaranayake, Ashok
Busch, Melanie A.
Gudgeon, Chelsea J.
Bates, Olivia M.
Olson, James M.
Mehlin, Christopher
Walter, Roland B.
author_sort Correnti, Colin E.
collection PubMed
description
format Online
Article
Text
id pubmed-5943151
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-59431512018-07-31 Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation Correnti, Colin E. Laszlo, George S. de van der Schueren, Willem J. Godwin, Colin D. Bandaranayake, Ashok Busch, Melanie A. Gudgeon, Chelsea J. Bates, Olivia M. Olson, James M. Mehlin, Christopher Walter, Roland B. Leukemia Article 2018-01-31 2018-05 /pmc/articles/PMC5943151/ /pubmed/29588544 http://dx.doi.org/10.1038/s41375-018-0014-3 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Correnti, Colin E.
Laszlo, George S.
de van der Schueren, Willem J.
Godwin, Colin D.
Bandaranayake, Ashok
Busch, Melanie A.
Gudgeon, Chelsea J.
Bates, Olivia M.
Olson, James M.
Mehlin, Christopher
Walter, Roland B.
Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
title Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
title_full Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
title_fullStr Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
title_full_unstemmed Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
title_short Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
title_sort simultaneous multiple interaction t-cell engaging (smite) bispecific antibodies overcome bispecific t-cell engager (bite) resistance via cd28 co-stimulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943151/
https://www.ncbi.nlm.nih.gov/pubmed/29588544
http://dx.doi.org/10.1038/s41375-018-0014-3
work_keys_str_mv AT correnticoline simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT laszlogeorges simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT devanderschuerenwillemj simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT godwincolind simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT bandaranayakeashok simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT buschmelaniea simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT gudgeonchelseaj simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT batesoliviam simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT olsonjamesm simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT mehlinchristopher simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation
AT walterrolandb simultaneousmultipleinteractiontcellengagingsmitebispecificantibodiesovercomebispecifictcellengagerbiteresistanceviacd28costimulation